Protein-coated corrole nanoparticles for the therapy of prostate most cancers cells
Growth of novel therapeutic methods to eradicate malignant tumors is of paramount significance in most cancers analysis. In a latest research, we now have launched a facile protocol for the preparation of corrole-protein nanoparticles (NPs). These NPs include a corrole-core coated with protein. We now report {that a} novel lipophilic corrole, (<b>2</b>)Ga, delivered as human serum albumin (HSA)-coated NPs, displayed antineoplastic exercise in the direction of human prostate most cancers DU-145 cells.
- Cryo-TEM evaluation of those NPs revealed a median diameter of 50.2 ± 8.1 nm with a spherical structure exhibiting low polydispersity.
- In vitro mobile uptake of (<b>2</b>)Ga/albumin NPs was attributable to speedy internalization of the corrole by means of ligand binding-dependent extracellular launch and intercalation of the corrole cargo into the lipid bilayer of the plasma membrane.
- This discovering is in distinction with a beforehand reported research on corrole-protein NPs that displayed mobile uptake through endocytosis.
- Investigation of the non-light-induced mechanism of motion of (<b>2</b>)Ga recommended the induction of necrosis by means of plasma membrane destabilization, impairment of calcium homeostasis, lysosomal stress and rupture, in addition to formation of reactive oxygen species (ROS).
- Ga additionally exhibited potent light-induced cytotoxicity by means of ROS era. These findings exhibit a speedy mobile uptake of (<b>2</b>)Ga/protein NPs together with focused induction of tumor cell necrosis.
Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates medical outcomes
Elevated ranges of pregnancy-associated plasma protein-A (PAPP-A) have been implicated within the pathogenesis of assorted malignancies, together with breast cancers. Breast most cancers is likely one of the most frequent carcinomas and is the second commonest most cancers kind detected in girls of child-bearing age.
All through pregnancy PAPP-A is produced and secreted by the placental syncytiotrophoblast cells; co-incidentally pregnancy-associated breast cancers usually have an aggressive medical course. The parts of the PAPP-A/IGF axis was assessed in a panel of breast most cancers cell strains. Utilizing neutralising antibodies the impression of PAPP-A/IGF axis on cell motility was evaluated.
PAPP-A was expressed in 4 of the twelve breast most cancers cell strainsexamined. Blocking PAPP-A and IGFBP4 with neutralising antibodies considerably decreased motiliy of MDA-MB-231 cells. Upregulation of PAPP-A expression in breast tumours resulted in a pattern in the direction of worse total survival. Notably, PAPP-A expression additionally positively correlated with epithelial-to-mesenchymal transition markers.
In conclusion, these outcomes point out that PAPP-A performs an essentialfunction in breast most cancersdevelopment and it might be a promising therapeutic goal in breast most cancers.

choleratox
Figuring out Antioxidant Proteins by Combining A number of Strategies
Antioxidant proteins play essential roles in stopping free radical oxidation from damaging cells and DNA. They’ve develop into preferrred candidates of illness prevention and therapy. Subsequently, it’s pressing to determine antioxidants from pure compounds.
Since experimental strategies are nonetheless value ineffective, a sequence of computational strategies have been proposed to determine antioxidant proteins. Nonetheless, the efficiency of the present strategies are nonetheless not passable. On this research, a assist vector machine based mostly technique, referred to as Vote9, was proposed to determine antioxidants, through which the sequences have been encoded through the use of the options generated from 9 optimum particular person fashions.
Outcomes from jackknife take a look at demonstrated that Vote9 is comparable with the perfect one of many current predictors for this activity. We hope that Vote9 will develop into a useful gizmo or a minimum of can play a complementary function to the prevailing strategies for figuring out antioxidants.
Rabbit Polyclonal antibody Anti-CRBN |
|||
Anti-CRBN | ImmunoStep | 50 µg | EUR 418.8 |
RAB11FIP3 Conjugated Antibody |
|||
C34950 | SAB | 100ul | EUR 476.4 |
RAB11FIP3 siRNA |
|||
20-abx930591 | Abbexa |
|
|
RAB11FIP3 siRNA |
|||
20-abx930592 | Abbexa |
|
|
Mouse RAB11FIP3 shRNA Plasmid |
|||
20-abx980932 | Abbexa |
|
|
Human RAB11FIP3 shRNA Plasmid |
|||
20-abx956495 | Abbexa |
|
|
RAB11FIP3 ELISA KIT|Human |
|||
EF002213 | Lifescience Market | 96 Tests | EUR 826.8 |
Polyclonal Goat anti-GST α-form |
|||
GST-ANTI-1 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST μ-form |
|||
GST-ANTI-2 | Detroit R&D | 50 uL | EUR 336 |
Polyclonal Goat anti-GST p-form |
|||
GST-ANTI-3 | Detroit R&D | 50 uL | EUR 336 |
Rab11fip3 ORF Vector (Mouse) (pORF) |
|||
ORF055392 | ABM | 1.0 ug DNA | EUR 607.2 |
Rab11fip3 ORF Vector (Mouse) (pORF) |
|||
ORF055393 | ABM | 1.0 ug DNA | EUR 607.2 |
Rab11fip3 ORF Vector (Mouse) (pORF) |
|||
ORF055394 | ABM | 1.0 ug DNA | EUR 607.2 |
RAB11FIP3 ORF Vector (Human) (pORF) |
|||
ORF028624 | ABM | 1.0 ug DNA | EUR 486 |
Rab11 Family-Interacting Protein 3 (RAB11FIP3) Antibody |
|||
20-abx014771 | Abbexa |
|
|
Rab11 family-interacting protein 3 (RAB11FIP3) Antibody |
|||
abx331334-100ul | Abbexa | 100 ul | EUR 510 |
Rab11 family-interacting protein 3 (RAB11FIP3) Antibody |
|||
20-abx326438 | Abbexa |
|
|
Rab11 Family-Interacting Protein 3 (RAB11FIP3) Antibody |
|||
abx236992-100ug | Abbexa | 100 ug | EUR 661.2 |
RAB11FIP3 sgRNA CRISPR Lentivector set (Human) |
|||
K1771301 | ABM | 3 x 1.0 ug | EUR 406.8 |
Rab11fip3 sgRNA CRISPR Lentivector set (Mouse) |
|||
K4045501 | ABM | 3 x 1.0 ug | EUR 406.8 |
RAB11FIP3 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K1771302 | ABM | 1.0 ug DNA | EUR 184.8 |
RAB11FIP3 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K1771303 | ABM | 1.0 ug DNA | EUR 184.8 |
RAB11FIP3 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K1771304 | ABM | 1.0 ug DNA | EUR 184.8 |
Rab11fip3 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
K4045502 | ABM | 1.0 ug DNA | EUR 184.8 |
Rab11fip3 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
K4045503 | ABM | 1.0 ug DNA | EUR 184.8 |
Rab11fip3 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
K4045504 | ABM | 1.0 ug DNA | EUR 184.8 |
RAB11FIP3 Protein Vector (Human) (pPB-C-His) |
|||
PV114494 | ABM | 500 ng | EUR 973.2 |
RAB11FIP3 Protein Vector (Human) (pPB-N-His) |
|||
PV114495 | ABM | 500 ng | EUR 973.2 |
RAB11FIP3 Protein Vector (Human) (pPM-C-HA) |
|||
PV114496 | ABM | 500 ng | EUR 973.2 |
RAB11FIP3 Protein Vector (Human) (pPM-C-His) |
|||
PV114497 | ABM | 500 ng | EUR 973.2 |
RAB11FIP3 Protein Vector (Mouse) (pPB-C-His) |
|||
PV221566 | ABM | 500 ng | EUR 723.6 |
RAB11FIP3 Protein Vector (Mouse) (pPB-N-His) |
|||
PV221567 | ABM | 500 ng | EUR 723.6 |
RAB11FIP3 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV221568 | ABM | 500 ng | EUR 723.6 |
RAB11FIP3 Protein Vector (Mouse) (pPM-C-His) |
|||
PV221569 | ABM | 500 ng | EUR 723.6 |
RAB11FIP3 Protein Vector (Mouse) (pPB-C-His) |
|||
PV221570 | ABM | 500 ng | EUR 1278 |
RAB11FIP3 Protein Vector (Mouse) (pPB-N-His) |
|||
PV221571 | ABM | 500 ng | EUR 1278 |
RAB11FIP3 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV221572 | ABM | 500 ng | EUR 1278 |
RAB11FIP3 Protein Vector (Mouse) (pPM-C-His) |
|||
PV221573 | ABM | 500 ng | EUR 1278 |
RAB11FIP3 Protein Vector (Mouse) (pPB-C-His) |
|||
PV221574 | ABM | 500 ng | EUR 1278 |
RAB11FIP3 Protein Vector (Mouse) (pPB-N-His) |
|||
PV221575 | ABM | 500 ng | EUR 1278 |
RAB11FIP3 Protein Vector (Mouse) (pPM-C-HA) |
|||
PV221576 | ABM | 500 ng | EUR 1278 |
RAB11FIP3 Protein Vector (Mouse) (pPM-C-His) |
|||
PV221577 | ABM | 500 ng | EUR 1278 |
Rab11fip3 3'UTR GFP Stable Cell Line |
|||
TU267172 | ABM | 1.0 ml | Ask for price |
RAB11FIP3 3'UTR Luciferase Stable Cell Line |
|||
TU019363 | ABM | 1.0 ml | EUR 1825.2 |
RAB11FIP3 3'UTR GFP Stable Cell Line |
|||
TU069363 | ABM | 1.0 ml | EUR 1825.2 |
Rab11fip3 3'UTR Luciferase Stable Cell Line |
|||
TU217172 | ABM | 1.0 ml | Ask for price |
Rab11fip3 3'UTR GFP Stable Cell Line |
|||
TU167386 | ABM | 1.0 ml | Ask for price |
Rab11fip3 3'UTR Luciferase Stable Cell Line |
|||
TU117386 | ABM | 1.0 ml | Ask for price |
Human Rab11 family-interacting protein 3 (RAB11FIP3) ELISA Kit |
|||
abx382597-96tests | Abbexa | 96 tests | EUR 1093.2 |
Mouse Rab11 family- interacting protein 3, Rab11fip3 ELISA KIT |
|||
ELI-52646m | Lifescience Market | 96 Tests | EUR 1038 |
Human Rab11 family- interacting protein 3, RAB11FIP3 ELISA KIT |
|||
ELI-41089h | Lifescience Market | 96 Tests | EUR 988.8 |
Human RAB11 Family Interacting Protein 3(RAB11FIP3)ELISA Kit |
|||
QY-E04676 | Qayee Biotechnology | 96T | EUR 433.2 |
ELISA kit for Human Rab11 family-interacting protein 3 (RAB11FIP3) |
|||
KTE63067-48T | Abbkine | 48T | EUR 424.8 |
Description: Quantitative sandwich ELISA for measuring Human Rab11 family-interacting protein 3 (RAB11FIP3) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Rab11 family-interacting protein 3 (RAB11FIP3) |
|||
KTE63067-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 2702.4 |
Description: Quantitative sandwich ELISA for measuring Human Rab11 family-interacting protein 3 (RAB11FIP3) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Rab11 family-interacting protein 3 (RAB11FIP3) |
|||
KTE63067-96T | Abbkine | 96T | EUR 686.4 |
Description: Quantitative sandwich ELISA for measuring Human Rab11 family-interacting protein 3 (RAB11FIP3) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
RAB11FIP3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K1771305 | ABM | 3 x 1.0 ug | EUR 451.2 |
Rab11fip3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
K4045505 | ABM | 3 x 1.0 ug | EUR 451.2 |
RAB11FIP3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
K1771306 | ABM | 1.0 ug DNA | EUR 200.4 |
RAB11FIP3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
K1771307 | ABM | 1.0 ug DNA | EUR 200.4 |
RAB11FIP3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
K1771308 | ABM | 1.0 ug DNA | EUR 200.4 |
Rab11fip3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
K4045506 | ABM | 1.0 ug DNA | EUR 200.4 |
Rab11fip3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
K4045507 | ABM | 1.0 ug DNA | EUR 200.4 |
Rab11fip3 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
K4045508 | ABM | 1.0 ug DNA | EUR 200.4 |
Anti-Anti-SEPT6 antibody antibody |
|||
STJ11100949 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
Anti-Anti-SEPT9 Antibody antibody |
|||
STJ111369 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ111530 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT4 Antibody antibody |
|||
STJ112276 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
Anti-Anti-MARCH9 Antibody antibody |
|||
STJ112609 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ113941 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
|||
STJ114081 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ114819 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-MARCH8 Antibody antibody |
|||
STJ114828 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ116214 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ117206 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT12 Antibody antibody |
|||
STJ117759 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118549 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH6 Antibody antibody |
|||
STJ118550 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-MARCH7 Antibody antibody |
|||
STJ118752 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT3 Antibody antibody |
|||
STJ118990 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ28365 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
|||
STJ28963 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT2 Antibody antibody |
|||
STJ25475 | St John's Laboratory | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
|||
STJ25477 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-SEPT8 Antibody antibody |
|||
STJ25479 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT1 antibody antibody |
|||
STJ119580 | St John's Laboratory | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
Anti-Anti-DDB1 Antibody |
|||
A00333 | BosterBio | 100uL | EUR 546 |
Description: Rabbit Polyclonal DDB1 Antibody. Validated in IP and tested in Human, Mouse. |
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
AEA465Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 6777.36 |
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
Immunodominant Mycobacterium tuberculosis Protein Rv1507A Elicits Th1 Response and Modulates Host Macrophage Effector Features
Mycobacterium tuberculosis (M. tb) persists as latent an infection in practically 1 / 4 of the worldwide inhabitants and stays the main reason behind dying amongst infectious ailments. Whereas BCG is the one vaccine for TB, its lack of ability to offer full safety makes it crucial to engineer BCG such that it expresses immunodominant antigens that may improve its protecting potential.
In-silico comparative genomic evaluation of Mycobacterium species recognized M. tb Rv1507A as a “signature protein” discovered solely in M. tb. In-vitro (cell strains) and in-vivo experiments carried out in mice, utilizing purified recombinant Rv1507A revealed it to be a pro-inflammatory molecule, eliciting considerably excessive ranges of IL-6, TNF-α, and IL-12.
There was elevated expression of activation markers CD69, CD80, CD86, antigen presentation molecules (MHC I/MHCII), and related Th1 kind of immune response. Rv1507A knocked-in M. smegmatis additionally induced considerably greater pro-inflammatory Th1 response and better survivability underneath stress situations, each in-vitro (macrophage RAW264.7 cells) and in-vivo (mice).
Sera derived from human TB sufferers confirmed considerably enhanced B-cell response towards M. tb Rv1507A. The power of M. tb Rv1507A to induce immuno-modulatory impact, B cell response, and important reminiscence response, renders it a putative vaccine candidate that calls for additional exploration.
Monoclonal Anti-M. tuberculosis 10 Kda cultural filtrate protein (CFP10) IgG |
|||
CFP101-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Monoclonal Anti-M. tuberculosis Rv1734 dormant protein from H37Rv strain IgG |
|||
RV17341-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Monoclonal Anti-M. tuberculosis Rv2031 dormant protein from H37Rv strain IgG |
|||
RV20311-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Monoclonal Anti-M. tuberculosis Rv2623 dormant protein from H37Rv strain IgG |
|||
RV26231-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Mouse Monoclonal Anti-Zaire Ebola virus (killed) IgG (mixture of EVZ12-M and EVZ13-M), aff pure |
|||
EVZ14-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Ammonium Bromide - 3 M (100ml) |
|||
M-CSS-423 | MiTeGen | 1 Unit | EUR 85 |
Description: Ammonium Bromide - 3 M (100ml) |
Imidazole, 1 M (100 ml) |
|||
M-CSS-512 | MiTeGen | 4 x 25 ml | EUR 79 |
Description: Imidazole, 1 M (100 ml) |
Monoclonal Anti-M. tuberculosis 10 Kda cultural filtrate protein (CFP10) IgG #2 |
|||
CFP102-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Monoclonal Anti-M. tuberculosis Heat Shock Protein 70 (hsp70/Dnak/ML2496) IgG |
|||
HSP701-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
1,6-Hexanediol, 5 M, 100 ML |
|||
M-CSS-109 | MiTeGen | 100 ml | EUR 70 |
Description: 1,6-Hexanediol, 5 M, 100 ML |
Ammonium Acetate, 5 M, 100 ML |
|||
M-CSS-129 | MiTeGen | 100 ml | EUR 70 |
Description: Ammonium Acetate, 5 M, 100 ML |
Ammonium Chloride, 5 M, 100 ML |
|||
M-CSS-131 | MiTeGen | 100 ml | EUR 70 |
Description: Ammonium Chloride, 5 M, 100 ML |
Ammonium Fluoride, 10 M, 100 ML |
|||
M-CSS-134 | MiTeGen | 4 x 25 ml | EUR 90 |
Description: Ammonium Fluoride, 10 M, 100 ML |
Ammonium Formate, 5 M, 100 ML |
|||
M-CSS-136 | MiTeGen | 100 ml | EUR 108 |
Description: Ammonium Formate, 5 M, 100 ML |
Ammonium Iodide, 1 M, 100 ML |
|||
M-CSS-137 | MiTeGen | 100 ml | EUR 108 |
Description: Ammonium Iodide, 1 M, 100 ML |
Ammonium Nitrate, 10 M, 100 ML |
|||
M-CSS-138 | MiTeGen | 100 ml | EUR 90 |
Description: Ammonium Nitrate, 10 M, 100 ML |
Ammonium Sulfate, 4 M, 100 ML |
|||
M-CSS-143 | MiTeGen | 100 ml | EUR 70 |
Description: Ammonium Sulfate, 4 M, 100 ML |
Cadmium Chloride, 1 M, 100 ML |
|||
M-CSS-151 | MiTeGen | 4 x 25 ml | EUR 108 |
Description: Cadmium Chloride, 1 M, 100 ML |
Cadmium Sulfate, 1 M, 100 ML |
|||
M-CSS-152 | MiTeGen | 4 x 25 ml | EUR 108 |
Description: Cadmium Sulfate, 1 M, 100 ML |
Cesium Chloride, 1 M, 100 ML |
|||
M-CSS-157 | MiTeGen | 100 ml | EUR 108 |
Description: Cesium Chloride, 1 M, 100 ML |
Lithium Nitrate, 8 M, 100 ML |
|||
M-CSS-204 | MiTeGen | 4 x 25 ml | EUR 108 |
Description: Lithium Nitrate, 8 M, 100 ML |
Lithium Sulfate, 2.5 M, 100 ML |
|||
M-CSS-207 | MiTeGen | 100 ml | EUR 77 |
Description: Lithium Sulfate, 2.5 M, 100 ML |
Sodium Malonate, 2 M, 100 ML |
|||
M-CSS-217 | MiTeGen | 100 ml | EUR 177 |
Description: Sodium Malonate, 2 M, 100 ML |
Potassium Acetate, 5 M, 100 ML |
|||
M-CSS-262 | MiTeGen | 100 ml | EUR 77 |
Description: Potassium Acetate, 5 M, 100 ML |
Potassium Bromide, 4 M, 100 ML |
|||
M-CSS-264 | MiTeGen | 100 ml | EUR 90 |
Description: Potassium Bromide, 4 M, 100 ML |
Potassium Formate, 10 M, 100 ML |
|||
M-CSS-269 | MiTeGen | 100 ml | EUR 130 |
Description: Potassium Formate, 10 M, 100 ML |
Potassium Iodide, 1 M, 100 ML |
|||
M-CSS-270 | MiTeGen | 100 ml | EUR 77 |
Description: Potassium Iodide, 1 M, 100 ML |
Potassium Nitrate, 1 M, 100 ML |
|||
M-CSS-272 | MiTeGen | 4 x 25 ml | EUR 77 |
Description: Potassium Nitrate, 1 M, 100 ML |
Potassium Sulfate 0.5 M, 100 ML |
|||
M-CSS-275 | MiTeGen | 100 ml | EUR 70 |
Description: Potassium Sulfate 0.5 M, 100 ML |
Potassium Thiocyanate, 2 M, 100 ML |
|||
M-CSS-276 | MiTeGen | 100 ml | EUR 90 |
Description: Potassium Thiocyanate, 2 M, 100 ML |
Sodium Acetate, 2.5 M, 100 ML |
|||
M-CSS-284 | MiTeGen | 100 ml | EUR 70 |
Description: Sodium Acetate, 2.5 M, 100 ML |
Sodium Bromide, 3 M, 100 ML |
|||
M-CSS-285 | MiTeGen | 100 ml | EUR 70 |
Description: Sodium Bromide, 3 M, 100 ML |
Sodium Chloride, 5 M, 100 ML |
|||
M-CSS-286 | MiTeGen | 100 ml | EUR 70 |
Description: Sodium Chloride, 5 M, 100 ML |
Sodium Fluoride, 1 M, 100 ML |
|||
M-CSS-290 | MiTeGen | 100 ml | EUR 77 |
Description: Sodium Fluoride, 1 M, 100 ML |
Sodium Formate, 5 M, 100 ML |
|||
M-CSS-291 | MiTeGen | 100 ml | EUR 77 |
Description: Sodium Formate, 5 M, 100 ML |
Sodium Iodide, 1 M, 100 ML |
|||
M-CSS-293 | MiTeGen | 100 ml | EUR 90 |
Description: Sodium Iodide, 1 M, 100 ML |
Sodium Nitrate, 7 M, 100 ML |
|||
M-CSS-294 | MiTeGen | 4 x 25 ml | EUR 77 |
Description: Sodium Nitrate, 7 M, 100 ML |
Sodium Sulfate, 1 M, 100 ML |
|||
M-CSS-300 | MiTeGen | 100 ml | EUR 62 |
Description: Sodium Sulfate, 1 M, 100 ML |
Sodium Thiocyanate, 8 M, 100 ML |
|||
M-CSS-303 | MiTeGen | 100 ml | EUR 90 |
Description: Sodium Thiocyanate, 8 M, 100 ML |
Zinc Chloride, 1 M, 100 ML |
|||
M-CSS-325 | MiTeGen | 4 x 25 ml | EUR 77 |
Description: Zinc Chloride, 1 M, 100 ML |
Lithium Chloride, 10 M, 100 ML |
|||
M-CSS-356 | MiTeGen | 100 ml | EUR 83 |
Description: Lithium Chloride, 10 M, 100 ML |
Potassium Chloride, 4 M, 100 ML |
|||
M-CSS-371 | MiTeGen | 100 ml | EUR 70 |
Description: Potassium Chloride, 4 M, 100 ML |
Hexadecyltrimethylammonium Bromide, 0.05 M, 100 ML |
|||
M-CSS-395 | MiTeGen | 100 ml | EUR 77 |
Description: Hexadecyltrimethylammonium Bromide, 0.05 M, 100 ML |
Succinic Acid, 0.5 M (100 ml) |
|||
M-CSS-522 | MiTeGen | 100 ml | EUR 48 |
Description: Succinic Acid, 0.5 M (100 ml) |
Monoclonal Anti-M. tuberculosis Heat Shock Protein 65 (hsp65/groEL-2/Cpn60-2) IgG |
|||
HSP651-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Ammonium dihydrogen Phosphate, 3 M, 100 ML |
|||
M-CSS-133 | MiTeGen | 100 ml | EUR 90 |
Description: Ammonium dihydrogen Phosphate, 3 M, 100 ML |
Calcium Acetate Hydrate, 1 M, 100 ML |
|||
M-CSS-153 | MiTeGen | 100 ml | EUR 77 |
Description: Calcium Acetate Hydrate, 1 M, 100 ML |
Calcium Chloride Dihydrate, 5 M, 100 ML |
|||
M-CSS-155 | MiTeGen | 100 ml | EUR 70 |
Description: Calcium Chloride Dihydrate, 5 M, 100 ML |
di-Ammonium Tartrate, 2 M, 100 ML |
|||
M-CSS-172 | MiTeGen | 100 ml | EUR 90 |
Description: di-Ammonium Tartrate, 2 M, 100 ML |
L-Glutathion reduced, 0.16 M, 100 ML |
|||
M-CSS-199 | MiTeGen | 100 ml | EUR 175 |
Description: L-Glutathion reduced, 0.16 M, 100 ML |
Lithium Citrate Hydrate, 1.5 M, 100 ML |
|||
M-CSS-203 | MiTeGen | 100 ml | EUR 77 |
Description: Lithium Citrate Hydrate, 1.5 M, 100 ML |
Magnesium Acetate Tetrahydrate, 1 M, 100 ML |
|||
M-CSS-210 | MiTeGen | 100 ml | EUR 90 |
Description: Magnesium Acetate Tetrahydrate, 1 M, 100 ML |
Magnesium Chloride Hexahydrate, 1 M, 100 ML |
|||
M-CSS-211 | MiTeGen | 100 ml | EUR 70 |
Description: Magnesium Chloride Hexahydrate, 1 M, 100 ML |
Magnesium Nitrate Hexahydrate, 1 M, 100 ML |
|||
M-CSS-214 | MiTeGen | 100 ml | EUR 70 |
Description: Magnesium Nitrate Hexahydrate, 1 M, 100 ML |
Magnesium Sulfate Heptahydrate, 2.5 M, 100 ML |
|||
M-CSS-216 | MiTeGen | 100 ml | EUR 90 |
Description: Magnesium Sulfate Heptahydrate, 2.5 M, 100 ML |
Nickel Sulfate Hexahydrate, 1 M, 100 ML |
|||
M-CSS-227 | MiTeGen | 4 x 25 ml | EUR 77 |
Description: Nickel Sulfate Hexahydrate, 1 M, 100 ML |
Potassium dihydrogen Phosphate, 1 M, 100 ML |
|||
M-CSS-268 | MiTeGen | 100 ml | EUR 62 |
Description: Potassium dihydrogen Phosphate, 1 M, 100 ML |
Zinc Acetate Dihydrate, 1 M, 100 ML |
|||
M-CSS-324 | MiTeGen | 4 x 25 ml | EUR 77 |
Description: Zinc Acetate Dihydrate, 1 M, 100 ML |
Zinc Sulfate Heptahydrate, 1 M, 100 ML |
|||
M-CSS-326 | MiTeGen | 4 x 25 ml | EUR 77 |
Description: Zinc Sulfate Heptahydrate, 1 M, 100 ML |
TBG pH 4.0, 1 M, 100 ML |
|||
M-CSS-384 | MiTeGen | 100 ml | EUR 108 |
Description: TBG pH 4.0, 1 M, 100 ML |
TBG pH 9.0, 1 M, 100 ML |
|||
M-CSS-385 | MiTeGen | 100 ml | EUR 108 |
Description: TBG pH 9.0, 1 M, 100 ML |
PCB pH 4.0, 1 M, 100 ML |
|||
M-CSS-387 | MiTeGen | 4 x 25 ml | EUR 122 |
Description: PCB pH 4.0, 1 M, 100 ML |
PCB pH 9.0, 1 M, 100 ML |
|||
M-CSS-388 | MiTeGen | 4 x 25 ml | EUR 122 |
Description: PCB pH 9.0, 1 M, 100 ML |
SPG pH 4.0, 1 M, 100 ML |
|||
M-CSS-389 | MiTeGen | 100 ml | EUR 77 |
Description: SPG pH 4.0, 1 M, 100 ML |
SPG pH 9.0, 1 M, 100 ML |
|||
M-CSS-390 | MiTeGen | 100 ml | EUR 77 |
Description: SPG pH 9.0, 1 M, 100 ML |
Magnesium Formate Dihydrate, 1 M, 100 ML |
|||
M-CSS-393 | MiTeGen | 100 ml | EUR 77 |
Description: Magnesium Formate Dihydrate, 1 M, 100 ML |
Sodium dihydrogen Phosphate, 1 M, 100 ML |
|||
M-CSS-394 | MiTeGen | 100 ml | EUR 70 |
Description: Sodium dihydrogen Phosphate, 1 M, 100 ML |
MMT pH 4.0, 1 M, 100 ML |
|||
M-CSS-398 | MiTeGen | 100 ml | EUR 96 |
Description: MMT pH 4.0, 1 M, 100 ML |
MMT pH 9.0, 1 M, 100 ML |
|||
M-CSS-399 | MiTeGen | 100 ml | EUR 96 |
Description: MMT pH 9.0, 1 M, 100 ML |
MIB pH 4.0, 1 M, 100 ML |
|||
M-CSS-400 | MiTeGen | 4 x 25 ml | EUR 81 |
Description: MIB pH 4.0, 1 M, 100 ML |
MIB pH 10.0, 1 M, 100 ML |
|||
M-CSS-401 | MiTeGen | 4 x 25 ml | EUR 81 |
Description: MIB pH 10.0, 1 M, 100 ML |
CHC pH 4.0, 1 M, 100 ML |
|||
M-CSS-402 | MiTeGen | 100 ml | EUR 122 |
Description: CHC pH 4.0, 1 M, 100 ML |
CHC pH 10.0, 1 M, 100 ML |
|||
M-CSS-403 | MiTeGen | 100 ml | EUR 122 |
Description: CHC pH 10.0, 1 M, 100 ML |
AAB pH 4.0, 1 M, 100 ML |
|||
M-CSS-404 | MiTeGen | 100 ml | EUR 96 |
Description: AAB pH 4.0, 1 M, 100 ML |
AAB pH 9.0, 1 M, 100 ML |
|||
M-CSS-405 | MiTeGen | 100 ml | EUR 96 |
Description: AAB pH 9.0, 1 M, 100 ML |
Cobalt(II) Chloride Hexahydrate, 1 M, 100 ML |
|||
M-CSS-163 | MiTeGen | 4 x 25 ml | EUR 108 |
Description: Cobalt(II) Chloride Hexahydrate, 1 M, 100 ML |
di-Ammonium hydrogen Phosphate, 3.5 M, 100 ML |
|||
M-CSS-171 | MiTeGen | 100 ml | EUR 90 |
Description: di-Ammonium hydrogen Phosphate, 3.5 M, 100 ML |
Ferric(III) Chloride Hexahydrate, 1 M, 100 ML |
|||
M-CSS-184 | MiTeGen | 4 x 25 ml | EUR 77 |
Description: Ferric(III) Chloride Hexahydrate, 1 M, 100 ML |
Nickel(II) Chloride Hexahydrate, 1 M, 100 ML |
|||
M-CSS-228 | MiTeGen | 4 x 25 ml | EUR 90 |
Description: Nickel(II) Chloride Hexahydrate, 1 M, 100 ML |
tri-Potassium Citrate Monohydrate, 2.5 M, 100 ML |
|||
M-CSS-266 | MiTeGen | 100 ml | EUR 77 |
Description: tri-Potassium Citrate Monohydrate, 2.5 M, 100 ML |
Potassium L-Tartrate Monobasic, 0.025 M, 100 ML |
|||
M-CSS-271 | MiTeGen | 100 ml | EUR 62 |
Description: Potassium L-Tartrate Monobasic, 0.025 M, 100 ML |
Sodium Tartrate dibasic Dihydrate, 1 M, 100 ML |
|||
M-CSS-301 | MiTeGen | 100 ml | EUR 108 |
Description: Sodium Tartrate dibasic Dihydrate, 1 M, 100 ML |
tri-Sodium Citrate Dihydrate, 1.6 M, 100 ML |
|||
M-CSS-319 | MiTeGen | 100 ml | EUR 77 |
Description: tri-Sodium Citrate Dihydrate, 1.6 M, 100 ML |
di-Potassium hydrogen Phosphate, 1 M, 100 ML |
|||
M-CSS-391 | MiTeGen | 100 ml | EUR 70 |
Description: di-Potassium hydrogen Phosphate, 1 M, 100 ML |